Although SIK inhibition is not involved in PTH-mediated phosphaturia, indirectly, SIK inhibition might even correct hyperphosphatemia in hypoparathyroidism, which is a consequence of absent PTH and inappropriately low FGF23. Here, PTH is linked to hyperphosphatemia.